Analyst price target range
National Health Investors Price Target: $81.88 Average
Direct answer
National Health Investors's average price target is $81.88.
The verified analyst range runs from $73.00 to $90.00.
The low target implies +11.1%, the high target implies +36.9%, and the range spans 25.9% of the current price.
Forecast evidence checked October 3, 2026.
Get free National Health Investors email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $65.72
- Average price target
- $81.88
- High price target
- $90.00
- Low price target
- $73.00
- Low target gap
- +11.1%
- Target upside
- +24.6%
- High target gap
- +36.9%
- Target range width
- 25.9%
- Consensus rating
- Buy
- Analysts
- 8
- Evidence date
- October 3, 2026
- Valid through
- October 10, 2026
Explore related company data
Read the frequently asked questions.
What is National Health Investors's average price target?
National Health Investors's verified average price target is $81.88. The target range is $73.00 to $90.00.
How far are National Health Investors's low and high targets from the recorded price?
The low target implies +11.1%, while the high target implies +36.9%.
How many analysts are included in National Health Investors's consensus?
The verified consensus includes 8 analysts.
How is National Health Investors's target upside or downside calculated?
The average target of $81.88 is divided by the recorded price of $65.72, then one is subtracted to produce +24.6%. This does not guarantee a future return.
When was National Health Investors's analyst forecast verified?
The data was verified on 2026-10-03. The dataset is valid through 2026-10-10.